Détail de l'auteur
Auteur Negroni E |
Documents disponibles écrits par cet auteur (44)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Yada E ; Pinto-Mariz F ; Negroni E ; Barthelemy I ; Blot S ; Savino W ; Voit T ; Mouly V ; Butler-Browne GS | 2011Duchenne muscular dystrophy (DMD) is an X-linked muscle wasting disease caused by the absence of functional dystrophin at the sarcolemma. There is currently no therapy for this disease, but stem cell-based cell therapy, eventually in combination[...]Article
Negroni E ; Vallese D ; Butler Browne G ; Trollet C ; Vilquin JT ; Butler-Browne GS ; Mouly V | 2011Accès au résumé PubMed / to PubMed abstractArticle
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Bencze M ; Negroni E ; Yacoub-Youssef H ; Chaouch S ; Wolff A ; Di Santo J ; Chazaud B ; Butler-Browne GS ; Savino W ; Mouly V ; Riederer I | 2011Cell therapy has been envisaged for some genetic muscular disorders using myoblasts in order to deliver the missing protein. Although pre-clinical trials in the mouse were promising, therapeutic trials using local injection of myoblasts failed t[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Chaouch S ; Mamchaoui K ; Trollet C ; Bigot A ; Negroni E ; Wolff A ; Kandalla P ; Marie S ; Di Santo J ; Muntoni F ; Lacau Saint Guily J ; Spuler S ; Philippi S ; Blumen S ; Furling D ; Voit T ; Wright W ; Aamiri A ; Butler-Browne GS ; Mouly V ; Kandalla PK ; Kim J ; Blumen SC ; Wright WE | AFM-TELETHON | 2011We recently generated immortalized human myoblast cell lines from control donors, by transduction of these cells with both telomerase (hTERT) and cyclin-dependent kinase 4 (CDK-4) expressing vectors. These cells maintain their potential to diffe[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Trollet C ; Anvar S ; Venema A ; Hargreaves I ; Foster K ; Vignaud A ; Ferry A ; Negroni E ; Gidaro T ; Hourde C ; Baraibar M ; Hoen P ; Davies J ; Rubinsztein D ; Heales S ; Mouly V ; van der Maarel S ; Raz V ; Butler Browne G ; Dickson G | AFM-TELETHON | 2011Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disorder characterized by ptosis, dysphagia and proximal limb weakness. Autosomal dominant OPMD is caused by a short (GCG)8-13 expansions within the first exon of the poly(A) binding pr[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Trollet C ; Perie S ; Gidaro T ; Mamchaoui K ; Negroni E ; Bouazza B ; Svinartchouk F ; Blumen S ; Mouly V ; Lacau Saint Guily J ; Butler Browne G | AFM-TELETHON | 2011Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant inherited, slow progressing, late onset degenerative muscle disorder, characterized by progressive eyelid drooping (ptosis) and difficulties with swallowing (dysphagia). The phar[...]Article
Mamchaoui K ; Trollet C ; Bigot A ; Negroni E ; Chaouch S ; Wolff A ; Kandalla PK ; Marie S ; Di Santo J ; Lacau Saint Guily J ; Muntoni F ; Kim J ; Philippi S ; Spuler S ; Blumen SC ; Voit T ; Wright WE ; Aamiri A ; Butler-Browne GS ; Mouly V | 2011Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Vallese D ; Negroni E ; Yada E ; Di Santo J ; Ferry A ; Vitiello L ; Mouly V ; Butler-Browne GS | 2011Cell therapy has been long explored as a potential approach for DMD, although the positive results obtained in animal models have been followed by discouraging evidences in clinical trials. This emphasized the importance of investigating the in [...]Article
Trollet C ; Anvar SY ; Venema A ; Hargreaves IP ; Foster K ; Vignaud A ; Ferry A ; Negroni E ; Hourde C ; Baraibar MA ; 't Hoen PAC ; Davies JE ; Rubinsztein DC ; Heales SJ ; van der Maarel SM ; Butler Browne G ; Raz V ; Dickson G ; t Hoen PAC ; Mouly V ; Butler-Browne GS | 2010Accès au résumé PubMed / to PubMed abstract 20/04/2010 - Dystrophie musculaire oculo-pharyngée : une nouvelle souris modèle de la maladie La dystrophie musculaire oculo-pharyngée (DMOP) est une maladie neuromusculaire due à une ex[...]Article
Negroni E ; Riederer I ; Wolff A ; Di Santo J ; Torrente Y ; Mouly V ; Butler-Browne GS | 10/2009After birth, adult skeletal muscle growth and repair are mediated by a population of cells, normally mitotically quiescent and located under the basal lamina of the myofibers, called satellite cells. In response to injury, resident satellite cel[...]Article
Chaouch S ; Goyenvalle A ; Vulin A ; Mamchaoui K ; Negroni E ; Di Santo J ; Butler Browne G ; Torrente Y ; Garcia L ; Furling D ; Mouly V ; Butler-Browne GS | 2009Accès au résumé PubMed / to PubMed abstractArticle
Negroni E ; Riederer I ; Chaouch S ; Belicchi M ; Razini P ; Di Santo J ; Torrente Y ; Butler-Browne GS ; Mouly V | 2009Accès au résumé PubMed / to PubMed abstractArticle
Heat shock treatment increases engraftment of human transplanted myoblasts into immunodeficient mice
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Bencze M ; Riederer I ; Negroni E ; Bigot A ; Butler-Browne GA ; Mouly V | 2008One of the phenomena known to limit the success of myoblast transfer therapy (MTT) is the massive and early cell death observed during the first few hours after cell injection. A major part of injected cells die by necrosis and apoptosis, thus d[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Riederer I ; Negroni E ; Bencze M ; Wolff A ; Savino W ; Butler-Browne GS ; Silva-Barbosa S ; Mouly V | 2008Myoblast transplant therapy (MTT) can be envisioned as a clinical alternative in the treatment of certain diseases. The problems that still remain to be solved to improve the efficiency of MTT are the massive early cell death, the limited prolif[...]Article
Riederer I ; Negroni E ; Bigot A ; Bencze M ; Di Santo J ; Aamiri A ; Butler-Browne GS ; Mouly V | 2008Accès au résumé PubMed / to PubMed abstractArticle
Mouly V ; Aamiri A ; Perie S ; Mamchaoui K ; Barani A ; Bigot A ; Bouazza B ; François V ; Furling D ; Jacquemin V ; Negroni E ; Riederer I ; Vignaud A ; Lacau Saint Guily J ; Butler-Browne GS | 2005Accès au résumé PubMed / to PubMed abstractArticle
Mouly V ; Aamiri A ; Bigot A ; Cooper RN ; Di Donna S ; Furling D ; Gidaro T ; Jacquemin V ; Mamchaoui K ; Negroni E ; Perie S ; Renault V ; Silva-Barbosa SD ; Butler-Browne GS | 2005Accès au résumé PubMed / to PubMed abstract 22/08/05 - De l’importance de l’horloge régissant la division cellulaire pour la régénération musculaire et ses applications en thérapeutique. La régénération musculaire squelettique dépend[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Riederer I ; Negroni E ; Bencze M ; Savino W ; Mouly V ; Silva-Barbosa SD ; Butler-Browne GS | 2005Communication n° 501 Myoblast transplant therapy (MTT) can be envisioned as a clinical alternative in the treatment of several myopathies. The problems that remain to be solved to improve the efficiency of MTT is the massive early death of trans[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Negroni E ; Mouly V ; Butler-Browne GS | 2005Communication n° 514 After birth, adult skeletal muscle growth and repair are mediated by a population of cells, normally mitotically quiescent and located under the basal lamina of the myofibers, called satellite cells. In response to muscle da[...]